Stocks and Investing
Stocks and Investing
Fri, September 2, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, September 1, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Douglas Miehm Maintained (BHC) at Hold with Increased Target to $8 on, Sep 1st, 2022
Douglas Miehm of RBC Capital, Maintained "Bausch Health Companies Inc." (BHC) at Hold with Increased Target from $4.5 to $8 on, Sep 1st, 2022.
Douglas has made no other calls on BHC in the last 4 months.
There are 3 other peers that have a rating on BHC. Out of the 3 peers that are also analyzing BHC, all agree with Douglas's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Gary Nachman of "BMO Capital" Maintained at Hold with Decreased Target to $8 on, Wednesday, August 10th, 2022
- Gregory Fraser of "Truist Securities" Downgraded from Strong Buy to Hold on, Friday, July 29th, 2022
- Chris Schott of "JP Morgan" Downgraded from Buy to Hold on, Friday, July 29th, 2022
Contributing Sources